Comparison of Dobutamine Transesophageal Echocardiography and Dobutamine Magnetic Resonance Imaging for Detection of Residual Myocardial Viability

This publication has 26 references indexed in Scilit:

• Comparison of Low-Dose Dobutamine–Gradient-Echo Magnetic Resonance Imaging and Positron Emission Tomography With [ ¹⁸ F]Fluorodeoxyglucose in Patients With Chronic Coronary Artery Disease
  Circulation, 1995
• Relation Between Thallium Uptake and Contractile Response to Dobutamine
  Circulation, 1995
• Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18 fluorodeoxyglucose positron emission tomography
  Journal of the American College of Cardiology, 1994
• Performance Evaluation of the Positron Scanner ECAT EXACT
  Journal of Computer Assisted Tomography, 1992
• Myocardial viability. What does it mean and how do we measure it?
  Circulation, 1991
• Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography
  Journal of the American College of Cardiology, 1990
• Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting
  The American Journal of Cardiology, 1989
• Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography.
  Circulation, 1986
• Reversal of dysfunction in postischemic stunned myocardium by epinephrine and postextrasystolic potentiation
  Journal of the American College of Cardiology, 1986
• Beta-adrenergic stimulation reverses postischemic myocardial dysfunction without producing subsequent functional deterioration
  The American Journal of Cardiology, 1985